Page 2 - Christopherk Murray News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Blueprint Medicines (NASDAQ:BPMC) Upgraded at SVB Leerink

Blueprint Medicines (NASDAQ:BPMC) Upgraded at SVB Leerink
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesPiper sandlerChristopherk murraySecurities exchange commissionChina universal asset management coBlueprint medicines corporationBlueprint medicines company profileAmerican century companies incRafferty asset managementBlueprint medicinesFree reportGet free reportExchange commissionAsset managementCentury companiesUniversal asset management

Blueprint Medicines (NASDAQ:BPMC) Raised to Market Perform at Leerink Partnrs

Blueprint Medicines (NASDAQ:BPMC) Raised to Market Perform at Leerink Partnrs
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United statesChristopherk murrayPiper sandlerLeerink partnrsSecurities exchange commissionBlueprint medicines corporationNeedham companyPolar capital holdings plcNorges bankBlueprint medicinesFree reportGet free reportExchange commissionCapital holdings plcSprings capital managementPartners management

Blueprint Medicines (NASDAQ:BPMC) PT Raised to $104 00

Blueprint Medicines (NASDAQ:BPMC) PT Raised to $104 00
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesChristopherk murrayPiper sandlerStifel nicolausJeffreyw albersPolar capital holdings plcBlueprint medicines corporationNorges bankBlueprint medicines company profileNeedham companySecurities exchange commissionBlueprint medicinesFree reportModerate buyGet free reportDirector jeffrey

Blueprint Medicines (NASDAQ:BPMC) Price Target Increased to $76 00 by Analysts at Citigroup

Blueprint Medicines (NASDAQ:BPMC – Free Report) had its price objective hoisted by Citigroup from $65.00 to $76.00 in a report issued on Friday, Benzinga reports. They currently have a sell rating on the biotechnology company’s stock. Other equities research analysts have also recently issued reports about the stock. Stifel Nicolaus upped their price objective on […]

United statesKate havilandStifel nicolausChristopherk murraySecurities exchange commissionFinancial services group incMirae asset global investments coAssociates corpBlueprint medicines corporationPrincipal financial group incBlueprint medicinesFree reportModerate buyMedicines trading downGet free reportExchange commission

Blueprint Medicines (NASDAQ:BPMC) Given New $104 00 Price Target at Piper Sandler

Blueprint Medicines (NASDAQ:BPMC – Free Report) had its price target lifted by Piper Sandler from $78.00 to $104.00 in a research note published on Friday, Benzinga reports. Piper Sandler currently has a neutral rating on the biotechnology company’s stock. Several other research firms also recently commented on BPMC. Wedbush reiterated an outperform rating and issued […]

United statesChristopherk murrayPiper sandlerNeedham companySecurities exchange commissionAmerican century companies incRafferty asset managementBlueprint medicines company profileChina universal asset management coBlueprint medicines corporationBlueprint medicinesFree reportModerate buyGet free reportExchange commissionAsset management